mesylate apatinib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for mesylate apatinib, covering 2018-08-29 to 2020-12-09. Get the full timeline:
Most recent: Clinical Trial Update: The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer [Phase 2]